Answers are grounded in this paper and cite their sources.
Case-control study demonstrates elevated urine and serum interleukin-6 titers correlated with tumor progression in bladder carcinoma, suggesting local urothelial immune activity.
To investigate the correlation between interleukin-6 and urothelial neoplasms, interleukin-6 activities in blood and urine samples of patients with bladder carcinoma were measured with a proliferation assay using an interleukin-6 dependent murine hybridoma clone, MH60.BSF2. A total of 43 patients and 15 normal volunteers were entered into this study. All of the patients were examined preoperatively and 26 were reexamined more than 6 days postoperatively to eliminate the effect of surgical injury on interleukin-6 secretion. The interleukin-6 titers in urine and serum increased in accordance with the progression of the tumor stage, and tumor removal induced a remarkable decrease in the titer of urinary interleukin-6. Although the interleukin-6-producing site has not been elucidated yet, our study suggests that interleukin-6 activity in bladder carcinoma patients may reflect the immunoreaction against the tumor in local urothelium.
No takes yet. Share an insight, caveat, or question.
Seguchi et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: